LensAR Inc. to Present Data From Laser Cataract Surgery Clinical Trial at the Annual Meeting of the American Academy of Ophthalmology
WINTER PARK, Fla., Oct. 13 -- LensAR, Inc., a leading developer of next generation laser technology for cataract surgery and other ocular applications, today announced that data from a recently completed clinical trial of the LensAR Laser System will be presented at the upcoming 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and Pan-American Academy of Ophthalmology (PAAO). The meeting will be held October 23 – 27, 2009 in San Francisco, CA.
Clinical investigator Louis D. “Skip” Nichamin, M.D., medical director of the Laurel Eye Clinic Center in Brookville, PA, will present LensAR’s clinical results in a paper entitled, “Laser Capsulotomy with the LensAR Laser System,” on Friday, October 23, 2009. The paper will be presented during Section II: Cataract and Refractive Surgery, “Refractive Surgery 2009: It’s Time to Change,” at 9:08 a.m. Pacific in Moscone Center West, Room 2014.
In addition to the data presentation, Ramon Naranjo-Tackman, M.D., principal investigator for LensAR’s clinical studies in Mexico, professor of ophthalmology at the Universidad Nacional Autonoma de Mexico, and director of corneal service at the Asociacion Para Evitar la Ceguera en Mexico, Hospital Luis Sanchez Bulnes in Mexico City will give a guest talk entitled, “Novel Uses of a Femtosecond Laser.” Dr. Naranjo will present an overview of the early experiences with capsulotomy and nuclear fragmentation with the LensAR Laser System. His talk will take place during Section XII: Pan-American Association of Ophthalmology (PAAO) Symposium, scheduled for Saturday, October 24, 2009 at 1:30 p.m. Pacific in Moscone Center West, Room 2014.
For a video demonstration of LensAR’s Laser System, please visit the company’s booth #547 at AAO-PAAO.
About LensAR, Inc.
LensAR, Inc. is a leading developer of next generation laser technology for cataract surgery and other ocular applications including presbyopia. The company has recently completed a laser cataract surgery clinical trial and filed a 510k application with the U.S. Food and Drug Administration. LensAR expects to commercialize its first systems in 2010. For more information on LensAR and its laser technology, please visit our website at www.lensarinc.com.
SOURCE LensAR, Inc.